WeRide Inc. — Board/Management Information 2005

Mar 18, 2005

==> picture [61 x 62] intentionally omitted <==

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED

(Incorporated in the Cayman Islands with limited liability) (Provisional Liquidators Appointed) (Stock Code: 399)

Changes in Directorships, Secretary and Principal Place of Business

Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) (the “Company”) announces that Mr. Yu Shiu Tin, Paul (“Mr. Yu”) resigned as an executive director of the Company with effect from 21 September 2004 due to personal reasons. The Company also announces that Mr. Hung Chen, Richael (“Mr. Hung”) resigned as an executive director of the Company with effect from 9 November 2004 because his salary had not been paid by the Company since September 2004.

Mr. Yu confirmed that there was no disagreement with the Board and there was no matter relating to his resignation that needed to be brought to the attention of the shareholders or creditors of the Company or The Stock Exchange of Hong Kong Limited. Mr. Hung has not indicated any disagreement with the Board and has not mentioned any matters relating to his resignation that needed to be brought to the attention of the shareholders or creditors of the Company or The Stock Exchange of Hong Kong Limited as at the date of this announcement.

The Company further announces that Ms. Choi Yik Ling, Kathy ceased to act as Secretary of the Company with effect from 8 October 2004.

In addition, the Company announces that the Company’s principal place of business in Hong Kong has changed to 26[th] Floor, Wing On Centre, 111 Connaught Road Central, Hong Kong with effect from 22 September 2004.

Please note that this announcement is only released on the AMS/3 Trading Terminal and the website of The Stock Exchange of Hong Kong Limited and has not been published in the newspapers as required by the Listing Rules due to the liquidity problems of the Company.

As at the date of this announcement, the Board of Directors of the Company consists of two independent non-executive directors, namely Mr. Chiu Koon Shou, Victor, and Mr. Lo Wah Wai, Lowell.

For and on behalf of Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) Darach E. Haughey Joint and Several Provisional Liquidator

Hong Kong, 17 March 2005